Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1997 1
2000 3
2001 2
2002 1
2004 2
2005 2
2006 6
2007 10
2008 10
2009 9
2010 12
2011 17
2012 14
2013 26
2014 19
2015 30
2016 34
2017 59
2018 66
2019 68
2020 93
2021 95
2022 118
2023 105
2024 106
2025 96
2026 59

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

934 results

Results by year

Filters applied: . Clear all
Page 1
Azathioprine.
Mohammadi O, Kassim TA. Mohammadi O, et al. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 31194347 Free Books & Documents.
This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team in the treatment of …
This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pha …
Insights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies.
Zehtabcheh S, Soleimani Samarkhazan H, Asadi M, Zabihi M, Parkhideh S, Mohammadi MH. Zehtabcheh S, et al. Biomark Res. 2025 May 13;13(1):73. doi: 10.1186/s40364-025-00786-y. Biomark Res. 2025. PMID: 40361241 Free PMC article. Review.
Therapeutically, there is a shift from chemotherapy to targeted therapies. Menin inhibitors (e.g., Revumenib, Ziftomenib) disrupt the Menin-KMT2A interaction, suppressing HOXA/MEIS1 and promoting differentiation. DOT1L inhibitors (e.g., Pinometostat) show promise in …
Therapeutically, there is a shift from chemotherapy to targeted therapies. Menin inhibitors (e.g., Revumenib, Ziftomenib) disrupt the …
Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches.
Mohammadi V, Maleki AJ, Nazari M, Siahmansouri A, Moradi A, Elahi R, Esmaeilzadeh A. Mohammadi V, et al. Stem Cell Rev Rep. 2024 Apr;20(3):585-600. doi: 10.1007/s12015-023-10668-1. Epub 2023 Dec 28. Stem Cell Rev Rep. 2024. PMID: 38153634 Review.
Different immune-modulatory therapies could be used, e.g., monoclonal-based immunotherapy, mesenchymal stem cell, and immune cell therapy. ...
Different immune-modulatory therapies could be used, e.g., monoclonal-based immunotherapy, mesenchymal stem cell, and immune cell the …
Chronic E-Cigarette Use Impairs Endothelial Function on the Physiological and Cellular Levels.
Mohammadi L, Han DD, Xu F, Huang A, Derakhshandeh R, Rao P, Whitlatch A, Cheng J, Keith RJ, Hamburg NM, Ganz P, Hellman J, Schick SF, Springer ML. Mohammadi L, et al. Arterioscler Thromb Vasc Biol. 2022 Nov;42(11):1333-1350. doi: 10.1161/ATVBAHA.121.317749. Epub 2022 Oct 26. Arterioscler Thromb Vasc Biol. 2022. PMID: 36288290 Free PMC article.
RESULTS: E-cigarette users and smokers had lower flow-mediated dilation (FMD) than nonusers. ...E-cigarette user sera caused increased endothelial release of H(2)O(2), and more permeability than nonuser sera. ...
RESULTS: E-cigarette users and smokers had lower flow-mediated dilation (FMD) than nonusers. ...E-cigarette user sera caused i …
Soluble E-cadherin: A marker of genital epithelial disruption.
Liu R, Armstrong E, Constable S, Buchanan LB, Mohammadi A, Galiwango RM, Huibner S, Perry MC, Prodger JL, Coburn B, Kaul R. Liu R, et al. Am J Reprod Immunol. 2023 Mar;89(3):e13674. doi: 10.1111/aji.13674. Epub 2023 Jan 12. Am J Reprod Immunol. 2023. PMID: 36593681
The purpose of this study was to evaluate soluble E-cadherin (sE-cad) as a marker of genital epithelial disruption. METHOD OF STUDY: Using in vitro models of endocervical and foreskin epithelial cells, we assessed changes in sE-cad, IL-6, IL-1beta, and IL-1alpha levels fol …
The purpose of this study was to evaluate soluble E-cadherin (sE-cad) as a marker of genital epithelial disruption. METHOD OF STUDY: …
Devising ethical codes for e-contents in e-learning.
Mohammadi A, Mojtahedzadeh R, Asadzandi S, Rashidi H. Mohammadi A, et al. Med J Islam Repub Iran. 2020 Mar 2;34:14. doi: 10.34171/mjiri.34.14. eCollection 2020. Med J Islam Repub Iran. 2020. PMID: 32551303 Free PMC article.
Methods: A draft of e-content ethical codes was prepared based on the literature review. Then, it was further revised by e-learning, medical education, ethics, and e-content experts. ...Conclusion: Considering the difference between e-content and other …
Methods: A draft of e-content ethical codes was prepared based on the literature review. Then, it was further revised by e-lea …
Ferroptosis in AML: nanoparticles, biomarkers, and immune rewiring for therapeutic breakthroughs.
Tavakoli F, Araskhan MA, Karimpour F, Soleimani Samarkhazan H, Hasheminasab H, Roshandel E, Vazifeh Shiran N, Dehghanifard A, Mohammadi MH. Tavakoli F, et al. Discov Oncol. 2025 Oct 21;16(1):1937. doi: 10.1007/s12672-025-03777-5. Discov Oncol. 2025. PMID: 41117998 Free PMC article. Review.
We explore cutting-edge pharmacological inducers (e.g., erastin, APR-246) and nanoparticle-based technologies (e.g., ferumoxytol, FAST nanoparticles) that enhance tumor selectivity and synergize with conventional therapies. ...
We explore cutting-edge pharmacological inducers (e.g., erastin, APR-246) and nanoparticle-based technologies (e.g., ferumoxyt …
934 results